Valneva SE
VALN
$6.86
$0.010.11%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/13/2026
-
MarketBeat
Valneva SE (VALN, $6.89) entered Downtrend as Momentum indicator drops below 0 level on Sep 04, 2026
9/6/2026
-
Tickeron - Stocks
9/4/2026
-
Tickeron - Stocks
9/3/2026
-
Tickeron - Stocks
9/2/2026
-
MarketBeat
9/1/2026
-
MarketBeat
Valneva SE (VALN, $6.43) entered Downtrend as Momentum indicator drops below 0 level on Aug 28, 2026
8/29/2026
-
Tickeron - Stocks
8/29/2026
-
Tickeron - Stocks
8/29/2026
-
Tickeron - Stocks
8/27/2026
-
Tickeron - Stocks
8/26/2026
-
Tickeron - Stocks
8/25/2026
-
MarketBeat
8/25/2026
-
Tickeron - Stocks
8/24/2026
-
MarketBeat
8/18/2026
-
MarketBeat
8/15/2026
-
Tickeron - Stocks
8/14/2026
-
MarketBeat
8/14/2026
-
The Cerbat Gem
8/14/2026
-
MarketBeat
8/14/2026
-
Tickeron - Stocks
8/14/2026
-
SeekingAlpha
8/14/2026
-
GuruFocus
8/14/2026
-
Business Wire
8/14/2026
-
Globe Newswire
8/13/2026
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
33 2 28 07 37 10
Address
6 rue Alain Bombard
Saint-Herblain, 44800
Saint-Herblain, 44800
Country
Year Founded
Business Description
Sector
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell...
more